O027 The combination of mandibular advancement devices (MAD) and supplemental oxygen dramatically improves OSA severity: preliminary results from the MADOX trial

INTRODUCTION: Patients with obstructive sleep apnoea (OSA) considered ‘non-responders’ to mandibular advancement device (MAD) therapy, typically have a high loop gain contributing to their OSA physiology. While MAD does not improve loop gain, other treatments such as supplemental oxygen can have a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, B, Vena, D, Thomson, L, Gikas, A, Radmand, R, Calianese, N, Hess, L, Landry, S, Joosten, S, Hamilton, G, Wellman, A, Sands, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109395/
http://dx.doi.org/10.1093/sleepadvances/zpab014.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109395/
http://dx.doi.org/10.1093/sleepadvances/zpab014.026

Ejemplares similares